American Century Companies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109M | Sell |
1,560,326
-460,303
| -23% | -$32.2M | 0.06% | 339 |
|
2025
Q1 | $149M | Buy |
2,020,629
+1,621,974
| +407% | +$119M | 0.09% | 215 |
|
2024
Q4 | $26.1M | Buy |
398,655
+20,348
| +5% | +$1.33M | 0.02% | 924 |
|
2024
Q3 | $29.5M | Sell |
378,307
-141,916
| -27% | -$11.1M | 0.02% | 851 |
|
2024
Q2 | $40.6M | Sell |
520,223
-327,510
| -39% | -$25.5M | 0.02% | 654 |
|
2024
Q1 | $57.4M | Buy |
847,733
+54,520
| +7% | +$3.69M | 0.04% | 495 |
|
2023
Q4 | $53.4M | Buy |
793,213
+64,667
| +9% | +$4.36M | 0.04% | 481 |
|
2023
Q3 | $49.3M | Sell |
728,546
-101,899
| -12% | -$6.9M | 0.04% | 462 |
|
2023
Q2 | $59.4M | Sell |
830,445
-148,278
| -15% | -$10.6M | 0.04% | 399 |
|
2023
Q1 | $66.4M | Buy |
978,723
+242,344
| +33% | +$16.4M | 0.05% | 358 |
|
2022
Q4 | $49.9M | Sell |
736,379
-425,524
| -37% | -$28.9M | 0.04% | 416 |
|
2022
Q3 | $63.7M | Buy |
1,161,903
+1,972
| +0.2% | +$108K | 0.06% | 338 |
|
2022
Q2 | $76.6M | Buy |
1,159,931
+6,557
| +0.6% | +$433K | 0.06% | 323 |
|
2022
Q1 | $76.5M | Sell |
1,153,374
-273,757
| -19% | -$18.2M | 0.05% | 345 |
|
2021
Q4 | $83.1M | Buy |
1,427,131
+120,193
| +9% | +$7M | 0.05% | 367 |
|
2021
Q3 | $78.5M | Buy |
1,306,938
+9,787
| +0.8% | +$588K | 0.05% | 352 |
|
2021
Q2 | $77.7M | Buy |
1,297,151
+1,250,180
| +2,662% | +$74.9M | 0.05% | 372 |
|
2021
Q1 | $2.34M | Buy |
46,971
+3,435
| +8% | +$171K | ﹤0.01% | 1116 |
|
2020
Q4 | $2.18M | Buy |
43,536
+9,755
| +29% | +$488K | ﹤0.01% | 1056 |
|
2020
Q3 | $1.85M | Buy |
33,781
+426
| +1% | +$23.3K | ﹤0.01% | 991 |
|
2020
Q2 | $1.76M | Buy |
33,355
+10,222
| +44% | +$541K | ﹤0.01% | 948 |
|
2020
Q1 | $1.03M | Buy |
23,133
+9,778
| +73% | +$437K | ﹤0.01% | 979 |
|
2019
Q4 | $666K | Buy |
+13,355
| New | +$666K | ﹤0.01% | 1138 |
|